Liu Fei, Jiang Zhili, Luo Wei, Yang Yunxiao, Guo Shuai, Yi Jiayi, Shen Geng, Li Wei, Wang Lin, Chen Xiuhuan, Zhi Zhaogong, Liu Tian, Zhao Xuedong, Li Chen, Gao Hai
Center of Coronary Heart Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Diabetol Metab Syndr. 2024 Dec 30;16(1):315. doi: 10.1186/s13098-024-01563-x.
Diabetes mellitus (DM) is a metabolic disorder with increasing prevalence and poor control rates, leading to adverse events. Prognostic nutritional value (PNI) has been identified as a protective factor in DM, but its role in uncontrolled DM remains unclear.
This study based on the representative cohort of National Health and Nutrition Examination Survey from 2005 to 2018. A total of 3,313 participants with uncontrolled DM were included in our analyses. PNI was calculated as 5×lymphocyte count (10/L)+ 10×serum albumin (g/L). The endpoints were DM-related and cardiovascular mortality, which were obtained from National Death Index. Univariable and multivariable cox proportional hazard regression were performed to investigate prognostic value of PNI.
Among 3,313 patients with uncontrolled DM (mean age of 61.75 ± 12.78 years, 53.4% male), PNI level was negatively associated with inflammatory markers and positively associated with metabolic markers of lipid and protein. During a median follow-up of 77 months, 247 DM-related deaths and 205 cardiovascular deaths occurred. Higher PNI levels independently predicted low DM-related (adjusted Hazard ratio [HR] = 0.872, 95% confidence interval [CI] 0.840-0.906, P < 0.001) and cardiovascular mortality (adjusted HR = 0.872, 95% CI 0.834-0.912, P < 0.001). The prognostic value of PNI significantly varied across different DM treatment conditions, which was more pronounced in patients receiving antidiabetic treatments (adjusted HR: insulin + oral antidiabetic drugs [OADs]: 0.832; insulin: 0.863; OADs: 0.894, all adjusted P < 0.001), but was absent in those without antidiabetic treatment.
A higher PNI level is an independent protective predictor for DM-related and cardiovascular mortality in uncontrolled DM patients. Evaluation of PNI level in uncontrolled DM patients could conduce to stringent intervention. Improvement of PNI could enhance the effective of antidiabetic therapy, especially the insulin therapy, and reduce DM-related mortality.
糖尿病(DM)是一种代谢紊乱疾病,其患病率不断上升且控制率不佳,会导致不良事件。预后营养指数(PNI)已被确定为糖尿病中的一个保护因素,但其在未控制的糖尿病中的作用仍不明确。
本研究基于2005年至2018年美国国家健康与营养检查调查的代表性队列。我们的分析共纳入了3313名未控制糖尿病的参与者。PNI的计算方法为5×淋巴细胞计数(10/L)+10×血清白蛋白(g/L)。终点为糖尿病相关死亡率和心血管死亡率,数据来自国家死亡指数。采用单变量和多变量Cox比例风险回归来研究PNI的预后价值。
在3313名未控制糖尿病的患者中(平均年龄61.75±12.78岁,53.4%为男性),PNI水平与炎症标志物呈负相关,与脂质和蛋白质的代谢标志物呈正相关。在中位随访77个月期间,发生了247例糖尿病相关死亡和205例心血管死亡。较高的PNI水平独立预测较低的糖尿病相关死亡率(调整后风险比[HR]=0.872,95%置信区间[CI]0.840 - 0.906,P<0.001)和心血管死亡率(调整后HR = 0.872,95%CI 0.834 - 0.912,P<0.001)。PNI的预后价值在不同的糖尿病治疗条件下有显著差异,在接受抗糖尿病治疗的患者中更为明显(调整后HR:胰岛素+口服抗糖尿病药物[OADs]:0.832;胰岛素:0.863;OADs:0.894,所有调整后P<0.001),但在未接受抗糖尿病治疗的患者中不存在这种差异。
较高的PNI水平是未控制糖尿病患者糖尿病相关死亡率和心血管死亡率的独立保护预测因素。评估未控制糖尿病患者的PNI水平有助于进行严格干预。改善PNI可提高抗糖尿病治疗的效果,尤其是胰岛素治疗,并降低糖尿病相关死亡率。